Berberine and the 'Nature's Ozempic' Claim: What Evidence Shows
Berberine lowers cholesterol and blood sugar in small trials, but comparing it to semaglutide misreads both the data and the biology.
Feb 14, 2024

Search
57 stories for“Big Ten”
Berberine lowers cholesterol and blood sugar in small trials, but comparing it to semaglutide misreads both the data and the biology.
Feb 14, 2024

Retatrutide just posted phase 3 weight loss data hitting three hormone receptors at once. Here is what is confirmed and what remains unproven.
May 27, 2026

Ozempic, Wegovy and Mounjaro are all prescribable in the UAE, but shortages and insurance gaps shape who can actually get them.
Mar 10, 2025

Insulin is a peptide. So is Ozempic. So is the unlabelled vial someone is selling on Telegram. The word describes a chemical class, not a level of evidence, and that gap is where the market lives.
Aug 11, 2026

Large trials with more than 30,000 participants found vitamin D pills do little for people who are not deficient, reshaping decades of assumptions.
Jan 20, 2026

VO2 max strongly predicts longevity, but the evidence that slow, low-intensity Zone 2 training is the best way to raise it is weaker than the trend suggests.
Jan 15, 2025

Peptide is a chemical category, not a claim. The two versions most people actually buy are the ones with the least regulation and, oddly, the best safety record. Here is what the trials support and what physics gets in the way of.
Aug 20, 2026
